Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc. -- Ignore unavailable to you. Want to Upgrade?

To: david brewer who wrote (1406)	2/4/2001 9:33:08 AM
From: Marc Phelan	Read Replies (1) \| Respond to of 1605

David, There are a number of items in the study that could be "construed" to benefit athletes or anyone else for that matter. "According to the study entitled, ``Intermittent Shear Stress Stimuli by Enhanced External Counterpulsation (EECP) Restores Endothelial Function in Patients with Coronary Artery Diseases'' by lead author, Hisashi Hurano, MD of the Kurume University School of Medicine in Kurume, Japan, the increased blood flow delivered to the body's vasculature during EECP therapy, appears to generate shear stress on the endothelial cells. Shear stress on these cells stimulates the release of nitric oxide (NO), a substance that allows vessels to vasodilate or relax. Vasodilation facilitates increased blood flow. Blood flow following EECP treatment, as measured by high resolution ultrasound, was found to increase three fold compared to baseline in the patients examined in this study." Source: biz.yahoo.com "EECP is a non-invasive outpatient therapy that utilizes pneumatic cuffs to compress the lower extremities in time with a patient's heartbeat. The therapy reduces angina symptoms by decreasing the heart's workload and improving circulation in areas of the heart deprived of adequate blood supply." Source: biz.yahoo.com "Vasomedical, Inc. (Nasdaq: VASO - news) announced today that a new study featured in the current issue of the highly respected Journal of the American College of Cardiology (JACC) showed that EECP® enhanced external counterpulsation therapy has a striking effect on the heart's ability to relax. ~ The results of the study show that EECP improved cardiac filling capacity function by several measures. In particular, pressure in the left ventricle decreased at the end of diastole and both the peak filling rate and the time to peak filling of the left ventricle improved significantly. Results also showed statistically significant improvement in all exercise tolerance parameters measured in the study, including exercise duration and time to ST-segment depression, important measures of the heart's response to exercise induced stress." Source: biz.yahoo.com Although this treatment is designed for those with heart problems I guess some could "stretch" the results to indicate that healthy individuals could also receive some benefit. Who knows? In any case it's exciting to see the health care implications of EECP. Marc